These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 28689967)
1. Cyclodextrin-Modified inorganic materials for the construction of nanocarriers. Cutrone G; Casas-Solvas JM; Vargas-Berenguel A Int J Pharm; 2017 Oct; 531(2):621-639. PubMed ID: 28689967 [TBL] [Abstract][Full Text] [Related]
2. Advantages of the combined use of cyclodextrins and nanocarriers in drug delivery: A review. Mura P Int J Pharm; 2020 Apr; 579():119181. PubMed ID: 32112928 [TBL] [Abstract][Full Text] [Related]
3. Effective combination treatment of lung cancer cells by single vehicular delivery of siRNA and different anticancer drugs. Li J; Wang Y; Xue S; Sun J; Zhang W; Hu P; Ji L; Mao Z Int J Nanomedicine; 2016; 11():4609-4624. PubMed ID: 27695321 [TBL] [Abstract][Full Text] [Related]
4. Interactions of Native Cyclodextrins with Metal Ions and Inorganic Nanoparticles: Fertile Landscape for Chemistry and Materials Science. Prochowicz D; Kornowicz A; Lewiński J Chem Rev; 2017 Nov; 117(22):13461-13501. PubMed ID: 29048880 [TBL] [Abstract][Full Text] [Related]
12. Recent advances and future directions in amphiphilic cyclodextrin nanoparticles. Bilensoy E; Hincal AA Expert Opin Drug Deliv; 2009 Nov; 6(11):1161-73. PubMed ID: 19705965 [TBL] [Abstract][Full Text] [Related]
13. Surfactant-free, drug-quantum-dot coloaded poly(lactide-co-glycolide) nanoparticles: towards multifunctional nanoparticles. Nehilla BJ; Allen PG; Desai TA ACS Nano; 2008 Mar; 2(3):538-44. PubMed ID: 19206580 [TBL] [Abstract][Full Text] [Related]
14. Multifunctional silica nanoparticles for targeted delivery of hydrophobic imaging and therapeutic agents. Liu Y; Mi Y; Zhao J; Feng SS Int J Pharm; 2011 Dec; 421(2):370-8. PubMed ID: 22001536 [TBL] [Abstract][Full Text] [Related]
15. The application of nanosponges to cancer drug delivery. Trotta F; Dianzani C; Caldera F; Mognetti B; Cavalli R Expert Opin Drug Deliv; 2014 Jun; 11(6):931-41. PubMed ID: 24811423 [TBL] [Abstract][Full Text] [Related]
16. A vision for cyclodextrin nanoparticles in drug delivery systems and pharmaceutical applications. Lakkakula JR; Maçedo Krause RW Nanomedicine (Lond); 2014 May; 9(6):877-94. PubMed ID: 24981652 [TBL] [Abstract][Full Text] [Related]
17. Novel nanoparticles made from amphiphilic perfluoroalkyl alpha-cyclodextrin derivatives: preparation, characterization and application to the transport of acyclovir. Ghera BB; Perret F; Chevalier Y; Parrot-Lopez H Int J Pharm; 2009 Jun; 375(1-2):155-62. PubMed ID: 19481701 [TBL] [Abstract][Full Text] [Related]
19. Recent advances in theranostic nanocarriers of doxorubicin based on iron oxide and gold nanoparticles. Gautier J; Allard-Vannier E; Munnier E; Soucé M; Chourpa I J Control Release; 2013 Jul; 169(1-2):48-61. PubMed ID: 23567046 [TBL] [Abstract][Full Text] [Related]